The FDA approved rifaximin, a non-absorbed antibiotic that remains within the body’s gastrointestinal system, for traveller’s diarrhea. This is in contrast to most other antibiotics which are spread throughout the body. Cipro or Bactrim are medications that are currently used.
A review article has suggested that this therapy may become the treatment of choice once routinely available.
Related posts:
- The Angry Pharmacist on the Medicare donut-hole
- E. Coli and diarrhea
- Bactrim for a UTI ends in death
- When ear piercings lead to keloid formation
- An iPod Touch for every medical student
- Denying experimental drugs to terminal patients: "Moronic cruelty"
- Fluoroquinolones get black boxed
KevinMD.com on Facebook
Comments on this entry are closed.